European Journal of Surgical Oncology
Volume 35, Issue 4 , Pages 339-347, April 2009

MicroRNAs: Key players in carcinogenesis and novel therapeutic targets

  • A.H.F. Mirnezami

      Affiliations

    • University Surgical Unit, Level F Centre Block, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 2380 796145.
  • ,
  • K. Pickard

      Affiliations

    • Cancer Sciences Division, University of Southampton, Southampton, UK
  • ,
  • L. Zhang

      Affiliations

    • Cancer Sciences Division, University of Southampton, Southampton, UK
  • ,
  • J.N. Primrose

      Affiliations

    • University Surgical Unit, Level F Centre Block, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK
  • ,
  • G. Packham

      Affiliations

    • Cancer Sciences Division, University of Southampton, Southampton, UK

Accepted 9 June 2008.

Abstract 

MicroRNAs (miRNAs) represent a recently uncovered class of small and endogenous non-coding RNAs. MiRNA function is critical to normal cellular processes such as differentiation and apoptosis, and recent studies have demonstrated that deregulated miRNA expression contributes to the malignant phenotype. The purpose of this review is to summarise these findings in relation to the most common human malignancies, and to analyse the clinical and therapeutic opportunities they provide.

Keywords: MicroRNA, Molecular profiling, Cancer, Clinical utility

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0748-7983(08)00202-3

doi:10.1016/j.ejso.2008.06.006

European Journal of Surgical Oncology
Volume 35, Issue 4 , Pages 339-347, April 2009